Capitalizing on AI to CapTure Undiagnosed Structural Heart Disease

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 4000 participants.

Also called NCT07843004

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose screening
Phase
Not applicable
Enrolled
  • 4,000 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07843004
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT07843004. Randomized; no masking; primary purpose screening. Start 2026-09-16 (actual); primary completion 2027-06-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Capitalizing on AI to CapTure Undiagnosed Structural Heart Disease
Acronym
CACTUS
Condition
Structural Heart Abnormality
Condition
Valve Heart Disease
Condition
Heart Diseases
Condition
Cardiovascular Diseases
Intervention (Device)
EHR Alert
Lead sponsor
Pierre Elias (class: other)
Collaborator
Edwards Lifesciences (class: industry)
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct07843004
Content hash
431f9e455cde5288936619bbf56c136a2fa188c568942ed2e7fb1fb78c299f7b